Markets.com Logo

MRNS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --$
  • Previous Close
    --$
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --$
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

MRNS.US represents the common stock of Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development and commercialization of innovative therapeutics to treat rare seizure disorders. Their primary focus is on developing ganaxolone, a neurosteroid GABAA receptor modulator, for indications like CDKL5 deficiency disorder, tuberous sclerosis complex-associated seizures, and refractory status epilepticus. The company's financial performance and stock price are influenced by clinical trial results, regulatory approvals, market competition, and overall investor sentiment toward the biotechnology sector.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

MRNS.US Stock Price Factors: Clinical Trial Results: Positive data from clinical trials for their drug candidates typically leads to a surge in stock price, while negative or inconclusive results can cause a significant decline.

Regulatory Approval: Receiving approval from regulatory bodies like the FDA is a major catalyst for stock appreciation. Conversely, rejection or delays in approval processes can negatively impact the stock.

Market Sentiment: General investor sentiment towards the biotechnology sector or small-cap stocks can influence MRNS.US, even without specific company news. Bullish markets tend to lift all stocks, while bearish markets can depress them.

Competition: The emergence of competing therapies or companies in the same therapeutic area can put pressure on MRNS.US, potentially reducing its market share and future revenue prospects.

Financial Performance: Company's cash runway, burn rate, and ability to secure funding significantly impact stock. Strong financial health signals stability, while concerns about funding can raise red flags.

Partnerships & Acquisitions: Strategic partnerships, collaborations, or potential acquisition offers can positively affect the stock price, reflecting confidence in the company's value and future potential.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--